Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps

Phase 3 Recruiting 280 enrolled Guangdong Hengrui Pharmaceutical Co., Ltd

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is being conducted to evaluate the efficacy, and safety of SHR-1905 injection in subjects with chronic rhinosinusitis with nasal polyps (CRSwNP)

Timeline

Start: 2025-08-28
Primary completion: 2028-04
Completion: 2028-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	SHR-1905	Monoclonal antibody	—	—

Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps

Summary

Timeline

Drugs

Indications